Cargando…
From inflammatory bowel disease to colorectal cancer: what’s the role of miRNAs?
Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease with relapse and remission periods. Ulcerative colitis and Crohn’s disease are two major forms of the disease. IBD imposes a lot of sufferings on the patient and has many consequences; however, the most important is the increased ris...
Autores principales: | Vaghari-Tabari, Mostafa, Targhazeh, Niloufar, Moein, Soheila, Qujeq, Durdi, Alemi, Forough, Majidina, Maryam, Younesi, Simin, Asemi, Zatollah, Yousefi, Bahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996392/ https://www.ncbi.nlm.nih.gov/pubmed/35410210 http://dx.doi.org/10.1186/s12935-022-02557-3 |
Ejemplares similares
-
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2022) -
MicroRNAs and Periodontal Disease: Helpful Therapeutic Targets?
por: Palideh, Abdolhakim, et al.
Publicado: (2023) -
Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
por: Moein, Soheila, et al.
Publicado: (2017) -
Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020) -
Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2020)